Fisent Technologies Announces Significant Growth in 2024 and Strong Momentum for Applied GenAI Process Automation Adoption in the Year Ahead
TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Fisent Technologies, a pioneer in…
With significant clinical results published in the Nature Medicine Journal, InBrain Pharma is about to durably modify the advanced Parkinson’s disease management
A World Premiere in Parkinson’s Disease With significant clinical results published in…
Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz
** IND submitted to the FDA showing significantly improved patient condition when…
Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3…
Trump Wins the U.S. Election: Cryptocurrency Staking Market Primed for Significant Growth with STAKING AI at the Helm
Los Angeles, CA, Nov. 08, 2024 (GLOBE NEWSWIRE) -- With the announcement…
NYSE: PACS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages PACS Group, Inc. (NYSE: PACS) Investors with Significant Losses to Contact the Firm
RADNOR, Pa.--(BUSINESS WIRE)--#classaction--The law firm of Kessler Topaz Meltzer & Check, LLP…
